An Open Letter to the Incoming Trump Administration About Psychedelics: A Five Part Plan

Psychedelic policy reform is the focus of a five-part open letter to the incoming Trump administration about how to improve access and accelerate research for mental health. The letter recommends moving psychedelics out of the most restrictive federal status by reclassifying them to Schedule III or IV, and it links this to reducing barriers for scientific study under the Controlled Substances Act. It also calls for increased federal research funding, expanded FDA pathways for “psychotherapeutic adjuvants” so therapy components can be treated as integral rather than as regulatory obstacles, and broader Right-to-Try access for terminal or treatment-resistant patients in controlled settings. Finally, it proposes creating a Veterans Affairs psychedelic research and treatment initiative to build protocolized psychedelic-assisted care for PTSD, depression, and substance use disorders.